Ivy Natal

San Francisco, United States

Ivy Natal develops a process to create human egg cells from skin samples as a treatment for most cases of infertility.

$1.5M raised

Jan 2022

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Ivy Natal raised?

Ivy Natal has raised $1.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2022.

Who are Ivy Natal's investors?

Ivy Natal's investors include SOSV, SOSV SF & NY (Fka IndieBio), Alameda Research.

Where is Ivy Natal headquartered?

Ivy Natal is headquartered in San Francisco, United States.

What does Ivy Natal do?

Ivy Natal develops a process to create human egg cells from skin samples as a treatment for most cases of infertility.

What stage is Ivy Natal at?

Ivy Natal is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 1, 2022.

MLA

"Ivy Natal — Funding & Investors." VCBacked, January 1, 2022, https://www.vcbacked.co/company/ivy-natal. Accessed July 4, 2026.

APA

VCBacked. (2022). Ivy Natal — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/ivy-natal

Wikipedia (cite web)

{{cite web |title=Ivy Natal — Funding & Investors |url=https://www.vcbacked.co/company/ivy-natal |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 1, 2022.